These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 17904950

  • 1. Postmarketing clinical experience in patients with skin and skin-structure infections treated with daptomycin.
    Owens RC, Lamp KC, Friedrich LV, Russo R.
    Am J Med; 2007 Oct; 120(10 Suppl 1):S6-12. PubMed ID: 17904950
    [Abstract] [Full Text] [Related]

  • 2. Daptomycin in the treatment of patients with infective endocarditis: experience from a registry.
    Levine DP, Lamp KC.
    Am J Med; 2007 Oct; 120(10 Suppl 1):S28-33. PubMed ID: 17904948
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
    Martone WJ, Lamp KC.
    Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
    [Abstract] [Full Text] [Related]

  • 4. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA, Hershberger E, Amodio-Groton MI, Lamp KC.
    Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
    [Abstract] [Full Text] [Related]

  • 5. Clinical experience with daptomycin for the treatment of patients with osteomyelitis.
    Lamp KC, Friedrich LV, Mendez-Vigo L, Russo R.
    Am J Med; 2007 Oct; 120(10 Suppl 1):S13-20. PubMed ID: 17904946
    [Abstract] [Full Text] [Related]

  • 6. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.
    Sakoulas G, Brown J, Lamp KC, Friedrich LV, Lindfield KC.
    Clin Ther; 2009 Sep; 31(9):1936-45. PubMed ID: 19843483
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Daptomycin versus other antimicrobial agents for the treatment of skin and soft tissue infections: a meta-analysis.
    Bliziotis IA, Plessa E, Peppas G, Falagas ME.
    Ann Pharmacother; 2010 Jan; 44(1):97-106. PubMed ID: 19934396
    [Abstract] [Full Text] [Related]

  • 11. Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infections.
    Kern WV.
    Int J Clin Pract; 2006 Mar; 60(3):370-8. PubMed ID: 16494659
    [Abstract] [Full Text] [Related]

  • 12. Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD.
    Eisenstein BI, Oleson FB, Baltz RH.
    Clin Infect Dis; 2010 Jan 01; 50 Suppl 1():S10-5. PubMed ID: 20067387
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    Lin DF, Zhang YY, Wu JF, Wang F, Zheng JC, Miao JZ, Zheng LY, Sheng RY, Zhou X, Shen HH, Ijzerman MM, Croos-Dabrera RV, Sheng W.
    Int J Antimicrob Agents; 2008 Sep 01; 32(3):241-9. PubMed ID: 18635341
    [Abstract] [Full Text] [Related]

  • 18. Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.
    Stryjewski ME, O'Riordan WD, Lau WK, Pien FD, Dunbar LM, Vallee M, Fowler VG, Chu VH, Spencer E, Barriere SL, Kitt MM, Cabell CH, Corey GR, FAST Investigator Group.
    Clin Infect Dis; 2005 Jun 01; 40(11):1601-7. PubMed ID: 15889357
    [Abstract] [Full Text] [Related]

  • 19. Clinical outcomes with daptomycin: a post-marketing, real-world evaluation.
    Sakoulas G.
    Clin Microbiol Infect; 2009 Dec 01; 15 Suppl 6():11-6. PubMed ID: 19917022
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.